| Dr Jennifer Albus Fehlman, MD | |
|
2315 Dougherty Ferry Rd Ste 200c, Saint Louis, MO 63122-3383 | |
| (314) 977-9666 | |
| (314) 977-9677 |
| Full Name | Dr Jennifer Albus Fehlman |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 2315 Dougherty Ferry Rd Ste 200c, Saint Louis, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134534811 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 2014017964 (Missouri) | Secondary |
| 207N00000X | Dermatology | 2018017647 (Missouri) | Primary |
| Entity Name | Ssm Health Care Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306589544 PECOS PAC ID: 0143608372 Enrollment ID: O20220531002655 |
News Archive
A National Cheng Kung University research team has made a breakthrough in the regeneration of new blood vessels in cardiovascular therapy by using nanofibers and vascular endothelial growth factor.
There is still much that is unknown about autism spectrum disorders, but a University of Nevada, Reno psychologist has added to the body of knowledge that researchers around the world are compiling to try to demystify, prevent and treat the mysterious condition.
International research co-led by professor Alejandro Maiche, of the Department of Basic, Evolutionary and Educational Psychology at the UAB, has put forward the hypothesis that the brain responds to the possibility that two objects might collide, in a different way to how it would react to two objects in movement with divergent trajectories.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major player in RNAi industry to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.
One of the newest product updates to be exhibited is MicroCare Duraglide® dry lubricant. Offering unparalleled lubricity, the fast-drying Duraglide® fluids leave a smooth, even, slippery coating on any surface...
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Albus Fehlman, MD 1008 S Spring Ave Fl 3, Saint Louis, MO 63110-2520 Ph: (314) 977-1771 | Dr Jennifer Albus Fehlman, MD 2315 Dougherty Ferry Rd Ste 200c, Saint Louis, MO 63122-3383 Ph: (314) 977-9666 |
News Archive
A National Cheng Kung University research team has made a breakthrough in the regeneration of new blood vessels in cardiovascular therapy by using nanofibers and vascular endothelial growth factor.
There is still much that is unknown about autism spectrum disorders, but a University of Nevada, Reno psychologist has added to the body of knowledge that researchers around the world are compiling to try to demystify, prevent and treat the mysterious condition.
International research co-led by professor Alejandro Maiche, of the Department of Basic, Evolutionary and Educational Psychology at the UAB, has put forward the hypothesis that the brain responds to the possibility that two objects might collide, in a different way to how it would react to two objects in movement with divergent trajectories.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major player in RNAi industry to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.
One of the newest product updates to be exhibited is MicroCare Duraglide® dry lubricant. Offering unparalleled lubricity, the fast-drying Duraglide® fluids leave a smooth, even, slippery coating on any surface...
› Verified 5 days ago
Dr. Caroline M Mann, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 969 N Mason Rd, Div Im Dermatology, Ste 220, Saint Louis, MO 63141 Phone: 314-273-3376 Fax: 888-682-0525 | |
Dr. Eva A. Hurst, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 969 N Mason Rd Ste 200, Ste 200, Saint Louis, MO 63141 Phone: 314-996-8810 Fax: 314-996-8775 | |
Shane A Grace, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12855 N 40 Dr Ste 180, Saint Louis, MO 63141 Phone: 314-878-5599 Fax: 314-392-4290 | |
Dr. Lee S Portnoff, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3009 N Ballas Rd, Ste 310a, Saint Louis, MO 63131 Phone: 314-993-2909 | |
Aibing Mary Guo, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 1225 S Grand Blvd Fl 3, Saint Louis, MO 63104 Phone: 314-977-3400 Fax: 314-977-7613 | |
Dr. Amy C Musiek, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4901 Forest Park Ave, Div Im Dermatology, Ste 502, Saint Louis, MO 63108 Phone: 314-273-3376 Fax: 888-665-8309 | |
Dr. Gillian Meade Heinecke, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1755 S Grand Blvd, Saint Louis, MO 63104 Phone: 314-256-3430 Fax: 314-256-3431 |